UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000003302
Receipt number R000003995
Scientific Title Phase I study of hepatic arterial infusion chemotherapy with Miriplatin and 5-fluorouracil(MiF) for advanced HCC
Date of disclosure of the study information 2010/04/01
Last modified on 2012/03/12 14:40:53

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Phase I study of hepatic arterial infusion chemotherapy with Miriplatin and 5-fluorouracil(MiF) for advanced HCC

Acronym

Phase I study of MiF for advanced HCC

Scientific Title

Phase I study of hepatic arterial infusion chemotherapy with Miriplatin and 5-fluorouracil(MiF) for advanced HCC

Scientific Title:Acronym

Phase I study of MiF for advanced HCC

Region

Japan


Condition

Condition

Hepatocellular carcinoma

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

This study assessed the safety and efficacy of MiF therapy for advavced HCC(not indicated transplantation, hepatic resection, TFA, TAE)

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Phase I


Assessment

Primary outcomes

complication

Key secondary outcomes

response evaluation
overall survival


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

inpatient therapy:administration via the implanted port of Miriplatin(65mg/m2,ia,day1) and 5-FU(850mg/m2,cia,day1-5and 8-12) into the hepatic artery.
outpatient therapy:administration via the implanted port of Mireplatin(35mg/m2,ia) and 5-FU(500mg/m2,cia) into the hepatic artery every two weeks.Repeat 5-10 courses.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

30 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

1.Histologically or clinically confirmed hepatocellular carcinoma.
2. No indication for transplantation or surgical resection.
3.Portal vein tumor thrombosis (main trunk or first,second branch)or multinodular tumor and maximum tumor size is >=50mm.
4.Ages 30 to 79 years old.
5.EOCG performance status is 0 or 1.
6.Life expectancy is more than 3 months.
7.Sufficient function of main organ(bone marrow,kidney,heart)and conditions filled the following criteria.
WBC>=2000/mm3
Hb>=8.5g/dL
Plt>=50,000/mm3
Child-Pugh score <9
T-bil=<2.0mg/dL
Without uncontrolled ascites and hepatic encephalopathy.
S-Cr=<1.5mg/dL
Ejection fraction>=45%
PaO2>=60mmHg
8.Written informed consent was obtained.

Key exclusion criteria

1.Previous chemothrapy or TAE
2.Previous operation or RFA or PEIT within 6 months.
3.Extrahepatic metastasis or lymph nodes metastasis.
4.Concurrent infections(without hepatitis virus)
5.Active double cancers
6.Medical history of severe hypersensitivity.
7.Pregnant,lacting women or women with suspected pregnancy.
8.Inappropriate patients for this study judged by physicians.

Target sample size

10


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Michio Sata

Organization

Kurume university School of Medicine

Division name

Division of Gastroenterology

Zip code


Address

67,Asahi-machi,Kurume-city,Fukuoka,830-0011,Japan

TEL

0942-31-7561

Email



Public contact

Name of contact person

1st name
Middle name
Last name Hiroaki Nagamatsu

Organization

Yame General Hospital

Division name

Department of Gastroenterology and Hepatology

Zip code


Address

540-2,Takatsuka,Yame-city,Fukuoka,834-0034

TEL

0943-23-4131

Homepage URL


Email

ymhp0389@yamehp.jp


Sponsor or person

Institute

Division of Gastroenterology,Kurume University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

公立八女総合病院(福岡県)


Other administrative information

Date of disclosure of the study information

2010 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

CR/PR/SD/PD:1/5/3/1

OS
6 months:90% , 12 manths:48%
MST:297 days

Safety: no ploblem

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2010 Year 02 Month 01 Day

Date of IRB


Anticipated trial start date

2010 Year 03 Month 01 Day

Last follow-up date

2012 Year 03 Month 01 Day

Date of closure to data entry

2012 Year 03 Month 01 Day

Date trial data considered complete

2012 Year 03 Month 01 Day

Date analysis concluded

2012 Year 03 Month 01 Day


Other

Other related information



Management information

Registered date

2010 Year 03 Month 09 Day

Last modified on

2012 Year 03 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003995


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name